Minerva Neurosciences receives Nasdaq delisting notice for MVLS non-compliance; to request hearing

Minerva Neurosciences, Inc.

Second Nasdaq notice for continued non-compliance with $35M minimum Market Value of Listed Securities; delisting determination unless hearing requested.
Company to request Nasdaq Hearings Panel hearing, which will stay suspension/delisting pending outcome.
Panel may grant extension to April 5, 2025; no guarantee of regaining compliance or continued listing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.